최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, v.24 no.2/3, 2014년, pp.67 - 70
Skov, J. , Frystyk, J. , Christiansen, J.S.
Objective: Glucagon-like peptide-1 (GLP-1) and the insulin-like growth factor (IGF) system are important factors in metabolic regulation and cellular growth. Interactions between the systems exist but these are vaguely explored and only in vitro, where GLP-1 has been reported to stimulate IGF-bindin...
Physiol. Rev. Holst 87 4 1409 2007 10.1152/physrev.00034.2006 The physiology of glucagon-like peptide 1
J. Clin. Pharm. Ther. Cornell 37 5 510 2012 10.1111/j.1365-2710.2012.01342.x Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes
Diabetes Obes Metab Wang 15 8 737 2013 10.1111/dom.12085 Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials
Br. Med. J. (Clin. Res. Ed.) Vilsboll 344 d7771 2012 10.1136/bmj.d7771 Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Endocr. Rev. Le Roith 22 1 53 2001 10.1210/edrv.22.1.0419 The somatomedin hypothesis: 2001
Growth Hormon. IGF Res. Juul 13 4 113 2003 10.1016/S1096-6374(03)00038-8 Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Am. J. Clin. Nutr. Brand-Miller 82 2 350 2005 10.1093/ajcn/82.2.350 The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects
J. Clin. Endocrinol. Metab. Arafat 94 12 5093 2009 10.1210/jc.2009-0875 The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity
Eur. J. Endocrinol. Chen 155 2 285 2006 10.1530/eje.1.02218 Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis
J. Clin. Endocrinol. Metab. Frystyk 82 9 3124 1997 The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults
Growth Hormon. IGF Res. Ivarsen 20 2 156 2010 10.1016/j.ghir.2009.12.001 Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis
J. Clin. Endocrinol. Metab. Brismar 79 3 872 1994 Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes
Growth Hormon. IGF Res. Hilding 12 1 60 2002 10.1054/ghir.2001.0262 Glucagon and GLP-1 stimulate IGFBP-1 secretion in Hep G2 cells without effect on IGFBP-1 mRNA
J. Clin. Endocrinol. Metab. Skov 98 4 E664 2013 10.1210/jc.2012-3855 Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men
J. Clin. Endocrinol. Metab. Krassas 88 1 132 2003 10.1210/jc.2002-021349 Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease
Am. J. Physiol. Endocrinol. Metab. Chen 284 6 E1149 2003 10.1152/ajpendo.00410.2002 A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum
BMC Nephrol. Reinhard 14 1 80 2013 10.1186/1471-2369-14-80 Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study
J. Clin. Endocrinol. Metab. Hilding 77 5 1142 1993 Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus
Diabetes Kjems 52 2 380 2003 10.2337/diabetes.52.2.380 The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects
Endocr. Rev. Samani 28 1 20 2007 10.1210/er.2006-0001 The role of the IGF system in cancer growth and metastasis: overview and recent insights
Diabetes Cornu 58 8 1816 2009 10.2337/db09-0063 Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.